Posts

Showing posts from July, 2026

The Hidden Markup in Cryostat Pricing

Image
 After sharing so much technical knowledge about pathology equipment with you all, today let's have a real, in-depth talk with our community about just how murky cryostat pricing can get. For anyone buying pathology equipment for the first time — whether a physician or a researcher — the current path to a purchase usually runs through one of two channels: searching online, or relying on knowledge passed down from more experienced colleagues. But as the internet era has advanced, person-to-person knowledge transfer has become rarer, especially among younger practitioners who increasingly prefer to just search online — and now, with AI in the picture, online research has come to outweigh in-person exchange entirely. People have very different opinions about this shift, and some countries have already stepped in to regulate it, particularly when it comes to minors. Of course, today we're here to talk about pathology equipment pricing, not that broader issue — I only mention it...

Why Are Domestic Pathology Equipment Manufacturers Always "Invisible" in Industry Reports?

Image
 For people working in the pathology industry, staying on top of industry trends and peer developments is extremely important. Getting your judgment right can help your company develop better within the industry; getting it wrong can lead to flawed decisions that may cause significant losses to the company. I am also someone who has spent 20 years in the medical industry, having worked across vaccine R&D, traditional Chinese medicine production, clinical research, and pathology equipment. Today I'd like to offer a brief analysis of the 2026-2031 China Pathology Diagnosis Industry Market Prospects and Investment Strategy Planning Analysis Report, published by the Qianzhan Industry Research Institute. In this report, China's pathology diagnosis industry is divided into two main tiers. The first tier consists of foreign-invested enterprises, including Roche, Leica, Sakura, Thermo Fisher, and others — the report considers this tier to dominate the high-end instrument and reag...

Frozen Section Technique: Step-by-Step Protocol and Key Optimization Tips

Frozen sectioning is a critical technique in histology and pathology for rapid tissue analysis. Achieving high-quality sections depends on precise control of temperature, blade condition, and cutting technique. Below is a practical step-by-step protocol along with key factors that influence section quality. Standard Frozen Section Procedure Mount the specimen holder with the embedded frozen sample onto the cryostat . Allow it to equilibrate for 20–30 minutes until the sample temperature matches the cryostat chamber. Note: Adjust temperature according to tissue type. Note: Always measure temperature near the specimen, not elsewhere in the chamber. Trim the block (trimming) and prepare the cutting surface. Note: Ensure continuous sectioning at 3–5 µm before collecting sections. Note: For hard tissues, avoid thick sections (>5 µm) to prevent blade damage. Apply firm, even pressure to stabilize the sectioning surface, and cut slowly at a constant speed. Remove the section from the cryo...

Routine Histopathology: A Complete Guide to Paraffin Embedding Technique

Image
 What Is Embedding? Embedding is the process by which tissue — after fixation, dehydration, clearing, and infiltration — is enclosed in an embedding medium to form a solid block. Embedding gives the tissue the hardness and firmness needed for thin sectioning. Different tissue types require different embedding media and embedding methods. Common embedding media include paraffin wax, resin, plastic, and celloidin. In routine histology labs, paraffin wax is the primary medium used. Embedding Tools and Preparation Embedding station (embedding center): the dedicated machine used for the procedure. Embedding paraffin: The paraffin used for embedding should match the paraffin used for infiltration in the tissue processor. It should have a melting point between 58°C and 62°C, and must be of high purity to avoid contaminating specimens or damaging microtome blades. Cassettes: Color-coded into four types — red, green, blue, and yellow. The appropriate color is selected at g...

下一代肾脏组织分析:当“空间组学”遇上“数字病理”

Image
 在肾脏病学研究中,理解病理过程是诊断、预测和判断疾病预后的金钥匙。尽管无创诊断技术近年来取得了长足进步,但肾脏疾病的许多关键病理机制依然深藏在组织内部,这使得对肾脏样本的深度剖析成为不可替代的刚需。 此前,以单细胞组学(Single-cell Omics)为代表的分子技术已经帮我们挖掘出了许多全新的疾病机制。 然而,这些传统的“非空间”方法有一个致命的短板——它们在提取细胞时必须打碎组织,丢失了细胞的“地理位置”(空间定位)和组织架构。 对于结构极其精细、细胞类型高度复杂的肾脏来说,不知道细胞“和谁做邻居”(细胞间相互作用),就无法真正看清疾病的全貌。 幸运的是, 空间组学 (Spatial Omics) 技术的爆发打破了这一僵局!它能够让我们在 维持组织结构完整的前提下,同步获取分子的精准画像与它们所在的空间背景 。 不仅如此,结合三维成像(如先进的 X 射线 CT、组织透明化技术等无损 3D 检测)与计算病理学(如病理组学 Pathomics),我们正在拉开一场肾脏病理学革命的帷幕。在不久的将来,这套多维度的整合方案不仅会重塑病理诊断的工作流,更将成为新药研发、发现预测性生物标志物(Biomarkers)和全新治疗靶点的终极利器。 核心前沿看点 📍 解密细胞“朋友圈” :空间组学不仅能识别出肾脏内部极其微细的细胞亚型,更能精准复原它们在空间上的相互作用,带我们看清肾脏在健康与疾病状态下,微环境究竟是如何“排兵布阵”的。 🛠️ 工欲善其事,必先利其器 :空间转录组、空间蛋白质组、空间代谢组……面对眼花缭乱的技术路线,深入理解不同方法的优缺点和适用边界,是决定科研课题能否取得突破性进展的第一步。 📸 无损 3D 视觉盛宴 :从二维切片走向三维时空!借助先进 X 射线 CT、 组织透明化 (Tissue Clearing)和高分辨电镜,科学家现在能对病变组织进行高分辨率、无损的 3D 病理学与分子层面的双重透视。 🤖 AI 赋能计算病理学 :人工智能正在重塑组织形态学分析。虽然目前计算肾脏病理学仍面临三大坎—— 数据集规模有限 、 罕见肾病种类繁多 以及 肾脏自身复杂的形态结构 ,但这也正是技术爆发的前夜。 📊 “小样本”也能撬动大发现 :肾脏病理组学(Pathomics)提供了一种高招——从常规组织病理切片中直接提取大规模、高通量的定量形态特征。...

Common Problems with H&E Sections and How to Fix Them

Image
  Histology sectioning rarely goes perfectly the first time. Below are the most frequent issues encountered when cutting and staining H&E sections, along with practical solutions for each. 1. Poor Tissue Fixation Cause: Tissue that was not properly fixed is dehydrated directly, resulting in blurred, unclear staining. Solution: After deparaffinizing and rehydrating the section, place it in AFA fixative or acetone for 5 minutes, rinse with water, then proceed with routine staining. AFA fixative: 850 mL 95% alcohol, 100 mL formalin, 50 mL acetic acid. 2. Holes in the Section The section shows holes (a sieve-like pattern) and appears broken or uneven. Solution: This is most common in lymph node and soft tissue samples. Advance the wax block slowly during cutting, trim the tissue gently, and rotate the section several times before lifting it until no holes remain. Causes of holes: Rough trimming done too fast or too aggressively; fine trimming insufficient. F...

Paraffin Sectioning: A Step-by-Step Lab Guide

Image
Paraffin sectioning uses a sharp microtome blade to cut tissue into ultra-thin layers for microscopic examination. Because raw tissue is too soft to cut on its own, it first goes through fixation, dehydration, and paraffin embedding — infiltrating the block with wax so it can hold its shape under the blade. This method preserves cell morphology and structural relationships so well that it remains the gold standard for light microscopy. What Makes a High-Quality Section A diagnostic-grade paraffin section should be: Structurally intact , with uniform thickness throughout Clean in staining — crisp red/blue contrast on H&E Free of defects — no knife marks, tears, or chatter lines Flat and wrinkle-free , with no folds or overlaps Uncontaminated , cleanly mounted with no air bubbles Securely adhered , positioned correctly on the slide Neatly labeled , with a straight, legible ID Before You Start Inspect the paraffin block and confirm the microtome blade is sharp Have...

Eco-Friendly Tissue Dehydration: H&E Staining Study

  The preparation of paraffin-embedded tissue blocks is a critical step in histopathological processing. This stage—commonly known as tissue dehydration—encompasses dehydration, clearing, and wax infiltration, typically carried out using automated tissue processors . Conventional dehydration protocols rely on reagents with well-documented toxicity profiles. In response, newer dehydration technologies built around eco-friendly tissue preparation reagents have gained substantial market share, owing to their clear environmental and occupational safety advantages. Yet systematic evidence on how these reagents affect the quality of hematoxylin and eosin (H&E) staining has remained limited—until now. This study closes that gap through a retrospective analysis of quality control data drawn from the pathology departments of eight hospitals over a full calendar year. The goal was threefold: to evaluate the real-world performance of an eco-friendly dehydration technology in paraffin ...

China's HER2-ADC Regimen Beats Chemo in NEJM Trial

Image
  China's HER2-ADC Regimen Beats Chemo in NEJM Trial Urothelial carcinoma — cancer of the bladder, renal pelvis, and ureter — is one of the most common cancers of the urinary system. In 2022 alone, China recorded 92,900 new cases and more than 40,000 deaths, with men far more affected than women and risk rising sharply after age 40. For nearly 50 years, cisplatin-based chemotherapy has been the default first-line treatment for locally advanced or metastatic disease. But it comes with a real cost: median survival of only 14–15 months, and toxicity so severe that many patients — especially those with kidney problems or poor overall health — simply can't tolerate it. Doctors have long needed something better. Now they may have it. A Chinese-Led Study Breaks Into NEJM The RC48-C016 trial , led by Prof. Jun Guo of Peking University Cancer Hospital and conducted by Prof. Xinan Sheng's team across 74 centers in China, is the first Phase III randomized trial to prove — hea...

Please share: